Literature DB >> 29520560

Effects of combined treatment of tadalafil and tamsulosin on bladder dysfunction via the inhibition of afferent nerve activities in a rat model of bladder outlet obstruction.

Akira Furuta1, Yasuyuki Suzuki2, Taro Igarashi3, Yusuke Koike3, Shin Egawa3, Naoki Yoshimura4.   

Abstract

PURPOSE: To investigate the effects of combined treatment of tadalafil (a phosphodiesterase-5 inhibitor) and tamsulosin (an α1-adrenoceptor antagonist) on bladder dysfunction in a rat model of bladder outlet obstruction (BOO).
METHODS: Cystometry was performed in conscious female BOO rats 6 weeks after partially ligation of the urethra. Either tadalafil (0.03, 0.1 and 0.3 mg/kg) or tamsulosin (0.001, 0.003 and 0.01 mg/kg) was cumulatively applied intravenously at 30-min intervals to examine changes in cystometric parameters and blood pressures. Changes in cystometric parameters and blood pressures were also checked when tadalafil (0.3 mg/kg), tamsulosin (0.003 mg/kg) or both were intravenously applied.
RESULTS: In BOO rats, application of either tadalafil (0.3 mg/kg) or tamsulosin (0.003, 0.01 mg/kg) alone significantly increased threshold pressures and intercontraction intervals whereas there were no significant changes in other cystometric parameters. In addition, because a significant reduction in blood pressures was detected after the administration of tamsulosin (0.01 mg/kg), tamsulosin at a lower dose (0.003 mg/kg) was used for the combined treatment. The combination therapy of tadalafil and tamsulosin induced a significantly larger rate of increase in intercontraction intervals (1.7 times) compared with monotherapy of either drug (1.3 times each) although the combined therapy did not affect blood pressures.
CONCLUSIONS: These results suggest that the combination therapy of tadalafil and tamsulosin can induce the additive inhibitory effects on urinary frequency compared with monotherapy, more likely via inhibition of the afferent limb of micturition reflex rather than the efferent function as evidenced by the increases in threshold pressures and intercontraction intervals without affecting bladder contractile function.

Entities:  

Keywords:  Bladder outlet obstruction; Combination therapy; Rats; Tadalafil; Tamsulosin

Mesh:

Substances:

Year:  2018        PMID: 29520560     DOI: 10.1007/s11255-018-1835-8

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  18 in total

1.  Different distribution of nitric oxide synthase and soluble guanylyl cyclase activities in the detrusor and proximal urethra of the rabbit.

Authors:  Hitoshi Masuda; Tetsuo Okuno; Masahito Suzuki; Kazunori Kihara; Moritaka Goto; Hiroshi Azuma
Journal:  J Urol       Date:  2002-11       Impact factor: 7.450

2.  Outline of JUA clinical guidelines for benign prostatic hyperplasia.

Authors:  Yukio Homma; Momokazu Gotoh; Osamu Yokoyama; Naoya Masumori; Akihiro Kawauchi; Tomonori Yamanishi; Osamu Ishizuka; Narihito Seki; Toshiyuki Kamoto; Atsushi Nagai; Seiichiro Ozono
Journal:  Int J Urol       Date:  2011-11       Impact factor: 3.369

3.  Effects of silodosin, a selective α1A-adrenoceptor antagonist, on bladder blood flow and bladder function in a rat model of atherosclerosis induced chronic bladder ischemia without bladder outlet obstruction.

Authors:  Yoshiaki Goi; Yoshitaka Tomiyama; Masanori Nomiya; Koji Sagawa; Ken Aikawa; Osamu Yamaguchi
Journal:  J Urol       Date:  2013-03-29       Impact factor: 7.450

4.  Effects of bladder outlet obstruction on properties of Ca2+-activated K+ channels in rat bladder.

Authors:  Masafumi Kita; Takakazu Yunoki; Koichi Takimoto; Minoru Miyazato; Kaori Kita; William C de Groat; Hidehiro Kakizaki; Naoki Yoshimura
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-03-03       Impact factor: 3.619

5.  Combination therapy with β3 -adrenoceptor agonists and muscarinic acetylcholine receptor antagonists: Efficacy in rats with bladder overactivity.

Authors:  Akira Furuta; Yasuyuki Suzuki; Shoji Kimura; Yusuke Koike; Shin Egawa; Naoki Yoshimura
Journal:  Int J Urol       Date:  2016-02-18       Impact factor: 3.369

6.  Co-administration of an α(1) -blocker improves the efficacy and safety of antimuscarinic agents in rats with detrusor overactivity.

Authors:  Keiko Nagase; Hideaki Ito; Yoshitaka Aoki; Kazuya Tanase; Hironobu Akino; Osamu Yokoyama
Journal:  Int J Urol       Date:  2011-10-13       Impact factor: 3.369

7.  Tadalafil enhances the inhibitory effects of tamsulosin on neurogenic contractions of human prostate and bladder neck.

Authors:  Javier Angulo; Pedro Cuevas; Argentina Fernández; José M La Fuente; Antonio Allona; Ignacio Moncada; Iñigo Sáenz de Tejada
Journal:  J Sex Med       Date:  2012-07-03       Impact factor: 3.802

8.  Functional roles of bladder α1-adrenoceptors in the activation of single-unit primary bladder afferent activity in rats.

Authors:  Naoki Aizawa; Rino Sugiyama; Koji Ichihara; Tetsuya Fujimura; Hiroshi Fukuhara; Yukio Homma; Yasuhiko Igawa
Journal:  BJU Int       Date:  2015-09-28       Impact factor: 5.588

9.  Prophylactic effect of tadalafil on bladder function in a rat model of chronic bladder ischemia.

Authors:  Masanori Nomiya; David Mark Burmeister; Norifumi Sawada; Lysanne Campeau; Mona Zarifpour; Tristan Keys; Charles Peyton; Osamu Yamaguchi; Karl-Erik Andersson
Journal:  J Urol       Date:  2012-10-08       Impact factor: 7.450

Review 10.  Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate.

Authors:  Martin C Michel; Wim Vrydag
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

View more
  1 in total

1.  Green & Sensitive pH-dependent Spectrofluorimetric Assay of Tamsulosin Hydrochloride and Tadalafil in their New Combined Formulation for Benign Prostatic Hyperplasia: Application to Spiked Human Plasma.

Authors:  Mona M Abdel Moneim
Journal:  J Fluoresc       Date:  2022-05-16       Impact factor: 2.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.